{"id":147094,"date":"2023-05-23T09:44:03","date_gmt":"2023-05-23T13:44:03","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147094"},"modified":"2023-05-23T09:44:04","modified_gmt":"2023-05-23T13:44:04","slug":"earnings-summary-of-dishman-carbogen-amcis-limited-for-q4-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-dishman-carbogen-amcis-limited-for-q4-fy23\/","title":{"rendered":"Earnings Summary Of Dishman Carbogen Amcis Limited For Q4 FY23"},"content":{"rendered":"<p>Dishman Carbogen Amcis Limited is a global pharmaceutical contract development and manufacturing organization (CDMO) that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialized drug products. With over three decades of experience, the company has established itself as a trusted partner for pharmaceutical companies worldwide. The company operates through three key business segments: the Development Solutions segment, the Manufacturing Solutions segment, and the Commercial Solutions segment.<\/p>\n<ul>\n<li>Dishman Carbogen Amcis Limited reported Total Income for Q4 FY23 of \u20b9625.31 Crore up from \u20b9573.36 Crore year on year, a growth of 9%.<\/li>\n<li>Total Expenses for Q4 FY23 of \u20b9667.29 Crore up from \u20b9646.52 Crore year on year, a growth of 3.2%.<\/li>\n<li>Consolidated Net Loss of \u20b970.72 Crore, widens from loss of \u20b944.62 Crore in the same quarter of the previous year.<\/li>\n<\/ul>\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"640\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8-1024x640.png\" alt=\"\" class=\"wp-image-147095\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8-1024x640.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8-300x187.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8-768x480.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8-1536x960.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8-2048x1280.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Dishman Carbogen Amcis Limited is a global pharmaceutical contract development and manufacturing organization (CDMO) that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialized drug products. With over three decades of experience, the company has established itself as a trusted partner for pharmaceutical companies worldwide. The company operates through three [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-147094","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":152137,"url":"https:\/\/alphastreet.com\/india\/dishman-carbogen-amcis-ltd-q1fy24-325-rise-in-profits\/","url_meta":{"origin":147094,"position":0},"title":"Dishman Carbogen Amcis Ltd Q1FY24; 325% rise in Profits","author":"Divyansh_Kasana","date":"August 9, 2023","format":false,"excerpt":"Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. Financial Results: Dishman Carbogen Amcis Ltd reported Revenues for Q1FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-488.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-488.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-488.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-488.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-488.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-488.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162389,"url":"https:\/\/alphastreet.com\/india\/dishman-carbogen-amcis-ltd-q4fy24-6-rise-in-revenue\/","url_meta":{"origin":147094,"position":1},"title":"Dishman Carbogen Amcis Ltd Q4FY24; 6% rise in Revenue","author":"Divyansh_Kasana","date":"June 20, 2024","format":false,"excerpt":"Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. Financial Results: Dishman Carbogen Amcis Ltd reported Revenues for Q4FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-182.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-182.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-182.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-182.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-182.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-182.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164557,"url":"https:\/\/alphastreet.com\/india\/dishman-carbogen-amcis-ltd-q1fy25-28-fall-in-revenue\/","url_meta":{"origin":147094,"position":2},"title":"Dishman Carbogen Amcis Ltd Q1FY25; 28% fall in Revenue","author":"Divyansh_Kasana","date":"September 27, 2024","format":false,"excerpt":"Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. Financial Results: Dishman Carbogen Amcis Ltd reported Revenues for Q1FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-106.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-106.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-106.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-106.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-106.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-106.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156936,"url":"https:\/\/alphastreet.com\/india\/dishman-carbogen-amcis-ltd-q2fy24-4-fall-in-revenue\/","url_meta":{"origin":147094,"position":3},"title":"Dishman Carbogen Amcis Ltd Q2FY24; 4% fall in Revenue","author":"Divyansh_Kasana","date":"November 30, 2023","format":false,"excerpt":"Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. Financial Results: Dishman Carbogen Amcis Ltd reported Revenues for Q2FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-428.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-428.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-428.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-428.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-428.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-428.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171116,"url":"https:\/\/alphastreet.com\/india\/dishman-carbogen-q1-fy26-earnings-results\/","url_meta":{"origin":147094,"position":4},"title":"Dishman Carbogen Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"September 10, 2025","format":false,"excerpt":"Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufactures and supplies marketable molecules including specialty chemicals, vitamins & chemicals, and disinfectants. The company has a presence in Switzerland, UK, Europe, China, and other countries. Presenting below its Q1FY26 Earnings Results. Q1 FY26 Earnings Results:\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"DCAL Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CAL.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CAL.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CAL.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CAL.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CAL.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/CAL.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":175739,"url":"https:\/\/alphastreet.com\/india\/dishman-carbogen-amcis-ltd-dcal-q2-2025-earnings-call-transcript\/","url_meta":{"origin":147094,"position":5},"title":"Dishman Carbogen Amcis Ltd (DCAL) Q2 2025 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Dishman Carbogen Amcis Ltd (NSE: DCAL) Q2 2025 Earnings Call dated Nov. 14, 2024 Corporate Participants: Pascal Villemagne \u2014 Chief Executive Officer Harshil R. Dalal \u2014 Global Chief Financial Officer Paolo Armanino \u2014 Chief Operating Officer India Analysts: Tarang Agrawal \u2014 Analyst Prit Nagersheth \u2014 Analyst Subrata Sarkar \u2014 Analyst\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147094"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147094\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}